Clinical Trial: A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Solid Tumors

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07591155) titled 'A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Solid Tumors' on May 09.

Brief Summary: This study is an open-label, multicenter, dose-escalation and expansion, non-randomized Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of BL-ARC002 for injection in patients with locally advanced or metastatic solid tumors.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Solid Tumors

Intervention: DRUG: BL-ARC002

Administration by intravenous infusion for a cycle of 6 weeks.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sichuan...